Showing results (571-580 of 2,814) with videos related to

Sort By:
Pageof 282
Diabetes Technology & Therapeutics|May 8, 2023
Glycemia Risk Index as a Novel Metric to Evaluate the Safety of Glycemic Control in Children and Adolescents with Type 1 Diabetes: An Observational, Multicenter, Real-Life Cohort StudyClaudia Piona, Marco Marigliano, Chiara Roncarà, et al.
Diabetes Technology & Therapeutics|May 15, 2023
Predicting Immunological Risk for Stage 1 and Stage 2 Diabetes Using a 1-Week CGM Home Test, Nocturnal Glucose Increments, and Standardized Liquid Mixed Meal Breakfasts, with Classification Enhanced by Machine LearningEslam Montaser, Marc D Breton, Sue A Brown, et al.
Diabetes Technology & Therapeutics|October 30, 2012
Rate of hypoglycemia in insulin-treated patients with type 2 diabetes can be predicted from glycemic variability dataYongming Qu, Scott J Jacober, Qianyi Zhang, et al.
Diabetes Technology & Therapeutics|October 30, 2012
Influence of local skin temperature and choice of insulin analog on catheter occlusion rates during continuous insulin infusion: an exploratory studySarita Naik, David Kerr, Joseph Begley, et al.
Diabetes Technology & Therapeutics|May 23, 2023
MiniMed 780G Advanced Hybrid Closed-Loop System Outcomes According to Pubertal Status: Awesome Study Group Real-Life ExperienceMarianna Rachmiel, Yael Lebenthal, Kineret Mazor-Aronovitch, et al.
Diabetes Technology & Therapeutics|April 1, 2015
Need for ethnic-specific guidelines for prevention, diagnosis, and management of type 2 diabetes in South asiansUsha Shrivastava, Anoop Misra
Diabetes Technology & Therapeutics|July 9, 2020
Usefulness and Safety of Remote Continuous Glucose Monitoring for a Severe COVID-19 Patient with DiabetesEmi Ushigome, Masahiro Yamazaki, Masahide Hamaguchi, et al.
Diabetes Technology & Therapeutics|May 15, 2014
A clinical utility index for selecting an optimal insulin dosing algorithm for LY2605541 in patients with type 2 diabetes pretreated with basal insulinDavid H Manner, Junxiang Luo, Yongming Qu, et al.
Diabetes Technology & Therapeutics|November 14, 2012
Continuous glucose monitoring: a valuable monitoring tool for management of hypoglycemia during chemotherapy for acute lymphoblastic leukemiaNipapat Visavachaipan, Alexander Aledo, Bonita H Franklin, et al.
Diabetes Technology & Therapeutics|January 10, 2014
Glycemic variability is higher in type 1 diabetes patients with microvascular complications irrespective of glycemic controlJan Šoupal, Jan Škrha, Martin Fajmon, et al.
Pageof 282